Concepedia

Author

Rekha Pal

University of Pittsburgh

Also Known As

R Pal, R. Pal, R.P. Pal, Rekha Pal, Rubi Pal -, Rupasree Pal

53

Publications

782

Citations

10

H-Index

30

Concepts

All Affiliations

University of PittsburghUPMC Hillman Cancer CenterUniversity of Pittsburgh Medical Center
RP

About

Rekha Pal is an author at University of Pittsburgh specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

394

2

Cell Biology

3

3

158

3

Health Sciences

1

1

11

4

Endocrinology

1

1

236

5

Neuroscience

1

1

236

Rekha Pal

×

10

Publications

739

Citations

10

H-Index

YearCitations

A phosphatidylinositol 3-kinase–phosphodiesterase 3B–cyclic AMP pathway in hypothalamic action of leptin on feeding

Allan Z. Zhao, Jjing-Ning Huan, Sandhya Gupta,

Nature Neuroscience

2002

236

Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL

Emre Sayan, R Stanford, Robert K. Vickery,

Oncogene

2011

122

IMiD immunomodulatory compounds block C/EBPβ translation through eIF4E down-regulation resulting in inhibition of MM

Shirong Li, Rekha Pal, Sara A. Monaghan,

Blood

2011

93

Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia

Rekha Pal, Sara A. Monaghan, Andrea Cortese Hassett,

Blood

2009

85

C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells

Rekha Pal, Martin Janz, Deborah L. Galson,

Blood

2009

76

Leptin Signaling in the Hypothalamus during Chronic Central Leptin Infusion

Rekha Pal, Abhiram Sahu

Endocrinology

2003

69

microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma

Rekha Pal, Stephanie Greene

PLoS ONE

2015

25

An Opposite Effect of the CDK Inhibitor, p18INK4c on Embryonic Stem Cells Compared with Tumor and Adult Stem Cells

Yanxin Li, Rekha Pal, Li‐Ying Sung,

PLoS ONE

2012

12

Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations

Rekha Pal, Ning Wei, Nan Song,

PLoS ONE

2018

11

Comparative molecular analysis of loss of heterozygosity in adenocarcinoma in bile duct brushings and corresponding surgical pathology specimens

N. Paul Ohori, Melissa H. Fowler, Patricia A. Swalsky,

Cancer

2003

10

Page 1